Schultz, Neil M.
Morga, Antonia
Siddiqui, Emad
Rhoten, Stephanie E.
Funding for this research was provided by:
Astellas Pharma
Article History
Received: 15 March 2023
Accepted: 1 November 2023
First Online: 21 November 2023
Declarations
:
: This analysis used data that were acquired from the SKYLIGHT 1 and 2 studies. These studies were conducted in accordance with the Declaration of Helsinki, Good Clinical Practice, and International Council for Harmonisation guidelines. An Independent Ethics Committee or Institutional Review Board reviewed the ethical, scientific, and medical appropriateness of the study at each site before data collection. Signed informed consent forms were obtained from the participants before any study-related procedures were performed.
: Not applicable.
: All authors have received support for medical writing. NMS, AM, and ES are employees of Astellas Pharma Inc. SER received consulting fees from IQVIA.